| Literature DB >> 25333366 |
Sandra Lösch1, Negahnaz Moghaddam1, Karl Grossschmidt2, Daniele U Risser3, Fabian Kanz3.
Abstract
The glEntities:
Mesh:
Substances:
Year: 2014 PMID: 25333366 PMCID: PMC4198250 DOI: 10.1371/journal.pone.0110489
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Study area at the west coast of Turkey.
(a) Geographical location of ancient Ephesus. (b) City map of Roman Ephesus with investigated excavations sites. (c) Details of the excavation trench in 1993 (DAM93) including the gladiator cemetery (DAM93G). Images compiled with modified data from OpenStreetMap and CIA maps.
Figure 2In situ gladiator tombstone excavated in the cemetery.
Individual data of stable carbon (C), nitrogen (N) and sulfur (S) isotope ratios for collagen and strontium (Sr), calcium (Ca) as well as Ca/P-ratios and Sr/Ca-ratios.
| Excavation complex | Sample-ID | Bone | Sex | δ13C [‰]V-PDB | δ15N [‰]AIR | δ34S [‰]V-CDT | %Ccoll | %N | %S | % Coll | C/N mol | C/S mol | N/S mol | Ca [mg/g] | Ca/P | Sr [μg/g] | Sr/Ca μg/mg] | |
| Gladiators | DAM93G | EPH-DAM 128/93 rFEM 5 | femur | M | −19.1 | 7.6 | 5.5 | 41.5 | 15.4 | 0.10 | 2.3 | 3.1 | 2.8 | 0.6 | 357.2 | 2.19 | 454.2 | 1.27 |
| DAM93G | EPH-DAM 146/93 rFEM 1 | femur | M | −19.3 | 10.6 | 7.5 | 39.3 | 14.7 | 0.06 | 2.1 | 3.1 | 2.0 | 0.4 | 362.5 | 2.25 | 583.1 | 1.61 | |
| DAM93G | EPH-DAM 155/93 rFEM 2 | femur | M | −19.0 | 9.2 | 8.4 | 35.9 | 14.0 | 0.10 | 1.8 | 3.0 | 1.7 | 0.4 | 365.2 | 2.21 | 380.5 | 1.04 | |
| DAM93G | EPH-DAM 155/93 rFEM 3 | femur | M | −18.9 | 9.8 | 8.3 | 40.6 | 14.9 | 0.07 | 2.6 | 3.2 | 1.8 | 0.4 | 358.3 | 2.18 | 429.4 | 1.20 | |
| DAM93G | EPH-DAM 155/93 rFEM 4 | femur | M | −19.4 | 8.7 | 8.0 | 38.2 | 15.1 | 0.12 | 2.2 | 3.0 | 1.9 | 0.4 | 358.8 | 2.16 | 279.4 | 0.78 | |
| DAM93G | EPH-DAM 155/93 rFEM 5 | femur | M | −19.0 | 8.4 | 8.9 | 40.6 | 15.4 | 0.11 | 2.1 | 3.1 | 1.7 | 0.3 | 383.7 | 2.33 | 562.8 | 1.47 | |
| DAM93G | EPH-DAM 155/93 rFEM 6 | femur | M | −18.8 | 8.7 | 8.2 | 41.1 | 16.3 | 0.11 | 5.0 | 2.9 | 2.0 | 0.4 | 349.1 | 2.23 | 335.3 | 0.96 | |
| DAM93G | EPH-DAM 187/93 rFEM 2 | femur | M | −18.5 | 9.4 | 9.7 | 42.8 | 15.9 | 0.10 | 5.2 | 3.1 | 1.6 | 0.3 | 367.7 | 2.22 | 630.5 | 1.71 | |
| DAM93G | EPH-DAM 187/93 rFEM 4 | femur | M | −19.0 | 9.6 | 5.7 | 41.7 | 16.4 | 0.10 | 4.5 | 3.0 | 2.9 | 0.5 | 341.6 | 2.26 | 449.0 | 1.31 | |
| DAM93G | EPH-DAM 187/93 rFEM 7 | femur | M | −19.3 | 9.4 | 9.0 | 38.2 | 15.4 | 0.10 | 3.1 | 2.9 | 1.7 | 0.3 | 358.7 | 2.24 | 434.9 | 1.21 | |
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| 374.5 | 2.25 | 543.0 | 1.45 | |
| DAM93G | EPH-DAM 187/93 rFEM 6 | femur | M | −17.8 | 8.9 | 5.9 | 41.7 | 15.6 | 0.15 | 1.1 | 3.1 | 2.6 | 0.5 | 355.8 | 2.29 | 379.6 | 1.07 | |
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| 374.1 | 2.35 | 724.9 | 1.94 | |
| DAM93G | EPH-DAM 199/93 rFEM 3 | femur | M | −18.6 | 9.7 | 6.4 | 40.2 | 15.4 | 0.12 | 2.2 | 3.0 | 2.4 | 0.5 | 370.1 | 2.33 | 712.9 | 1.93 | |
| DAM93G | EPH-DAM 199/93 rFEM 4 | femur | N/A | −18.8 | 9.2 | 8.9 | 40.5 | 15.4 | 0.08 | 3.5 | 3.1 | 1.7 | 0.3 | N/A | N/A | N/A | N/A | |
| DAM93G | EPH-DAM 248/93 rFEM 1 | femur | M | −19.2 | 8.6 | 4.5 | 45.3 | 17.0 | 0.10 | 2.4 | 3.1 | 3.8 | 0.7 | 361.6 | 2.26 | 499.0 | 1.38 | |
| DAM93G | EPH-DAM 248/93 rFEM 3 | femur | M | −19.3 | 10.1 | 8.7 | 41.3 | 15.5 | 0.11 | 3.8 | 3.1 | 1.8 | 0.4 | 376.9 | 2.27 | 359.4 | 0.95 | |
| DAM93G | EPH-DAM 248/93 rFEM 5 | femur | M | −19.1 | 8.8 | 8.8 | 41.6 | 15.4 | 0.12 | 2.8 | 3.2 | 1.7 | 0.4 | 355.3 | 2.26 | 405.7 | 1.14 | |
| DAM93G | EPH-DAM 248/93 rFEM 6 | femur | M | −18.2 | 9.9 | 11.2 | 42.7 | 16.7 | 0.10 | 4.2 | 3.0 | 1.5 | 0.3 | 359.2 | 2.20 | 453.5 | 1.26 | |
| DAM93G | EPH-DAM 76/93 rFEM 2 | femur | M | −18.5 | 11.2 | 7.0 | 42.6 | 15.9 | 0.11 | 3.9 | 3.1 | 2.3 | 0.4 | 365.0 | 2.29 | 334.5 | 0.92 | |
| DAM93G | EPH-DAM 78/93 rFEM 3 | femur | M | −18.4 | 9.2 | 6.9 | 43.6 | 16.2 | 0.11 | 3.9 | 3.1 | 2.4 | 0.5 | 373.0 | 2.27 | 376.4 | 1.01 | |
| DAM93G | EPH-DAM 83/93 rFEM 2 | femur | M | −19.4 | 9.8 | 3.4 | 39.4 | 15.1 | 0.09 | 4.4 | 3.0 | 4.4 | 0.9 | 360.7 | 2.20 | 330.7 | 0.92 | |
| NG-males | DAM93NG | EPH-DAM 106/93 FEM | femur | M | −19.1 | 8.8 | 6.4 | 40.9 | 15.4 | 0.15 | 2.5 | 3.1 | 2.4 | 0.5 | 353.1 | 2.26 | 248.7 | 0.70 |
| DAM93NG | EPH-DAM 108/93 MAN | mandibula | M | <LOD | N/A | N/A | N/A | N/A | ||||||||||
| DAM94 | EPH-DAM 143/94 lFEM 1 | femur | M | −18.9 | 9.4 | 8.4 | 38.7 | 14.3 | 0.06 | 2.1 | 3.2 | 1.7 | 0.4 | 374.5 | 2.17 | 264.0 | 0.70 | |
| DAM94 | EPH-DAM 143/94 lFEM 2 | femur | M | −19.0 | 10.4 | 7.6 | 37.8 | 14.6 | 0.08 | 2.5 | 3.0 | 1.9 | 0.4 | 361.8 | 2.24 | 301.4 | 0.83 | |
| DAM94 | EPH-DAM 163/94 lHUM 1 | humerus | M | −18.8 | 8.8 | 5.7 | 41.7 | 16.0 | 0.10 | 3.6 | 3.0 | 2.8 | 0.5 | 370.9 | 2.25 | 226.4 | 0.61 | |
| DAM94 | EPH-DAM 163/94 lHUM 4 | humerus | M | −18.8 | 8.9 | 6.8 | 38.5 | 15.6 | 0.06 | 2.3 | 2.9 | 2.3 | 0.4 | 368.9 | 2.26 | 269.2 | 0.73 | |
| DAM94 | EPH-DAM 163/94 lHUM 5 | humerus | M | −19.6 | 10.5 | 7.0 | 41.2 | 16.2 | 0.06 | 2.4 | 3.0 | 2.3 | 0.4 | 359.3 | 2.29 | 302.9 | 0.84 | |
| DAM93NG | EPH-DAM 191/93 rHUM | humerus | M | −19.0 | 8.8 | 8.8 | 38.9 | 14.9 | 0.09 | 3.0 | 3.0 | 1.7 | 0.3 | 356.5 | 2.25 | 195.7 | 0.55 | |
| DAM94 | EPH-DAM 191/94 lFEM 1 | femur | M | −18.9 | 10.0 | 6.8 | 41.2 | 15.1 | 0.13 | 1.8 | 3.2 | 2.2 | 0.5 | 374.6 | 2.30 | 195.6 | 0.52 | |
| DAM94 | EPH-DAM 191/94 lFEM 2 | femur | M | −18.9 | 9.0 | 5.4 | 37.5 | 14.9 | 0.06 | 2.4 | 2.9 | 2.8 | 0.5 | 358.0 | 2.25 | 236.7 | 0.66 | |
| DAM94 | EPH-DAM 204/94 lFEM-1 | femur | M | <LOD | N/A | N/A | N/A | N/A | ||||||||||
| DAM94 | EPH-DAM 325+327/94 lHUM | humerus | M | −19.3 | 9.2 | 9.1 | 40.6 | 15.0 | 0.10 | 3.4 | 3.2 | 1.7 | 0.3 | 369.8 | 2.32 | 226.6 | 0.61 | |
| DAM92 | EPH-DAM FEIGEN 1/92 FEM 2 | femur | M | −18.7 | 9.2 | 7.7 | 41.9 | 15.8 | 0.12 | 6.0 | 3.1 | 2.1 | 0.4 | 349.7 | 2.25 | 236.2 | 0.68 | |
| DAM92 | EPH-DAM FEIGEN 3/92 lPAT 8 | patella | M | −18.9 | 9.1 | 6.9 | 42.3 | 15.5 | 0.11 | 5.1 | 3.2 | 2.2 | 0.5 | N/A | N/A | N/A | N/A | |
| DAM92 | EPH-DAM FEIGEN 3/92 TIB 4 | tibia | M | −18.7 | 9.4 | 8.1 | 43.1 | 16.3 | 0.10 | 6.4 | 3.1 | 2.0 | 0.4 | N/A | N/A | N/A | N/A | |
| Females | DAM93NG | EPH-DAM 106/93 PAR 2 | skull | F | −19.4 | 7.4 | 6.9 | 43.9 | 16.3 | 0.07 | 1.4 | 3.1 | 2.4 | 0.5 | N/A | N/A | N/A | N/A |
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| 367.9 | 2.21 | 247.4 | 0.67 | |
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| N/A | N/A | N/A | N/A | |
| DAM94 | EPH-DAM 307/94 lHUM | humerus | F | −19.2 | 8.8 | 3.9 | 40.6 | 15.7 | 0.09 | 8.9 | 3.0 | 4.0 | 0.8 | 371.8 | 2.28 | 240.4 | 0.65 | |
| DAM93NG | EPH-DAM 72/93 rFEM 1 | femur | F | −18.2 | 9.5 | 11.2 | 38.7 | 14.8 | 0.06 | 3.3 | 3.0 | 1.3 | 0.3 | 370.7 | 2.26 | 236.0 | 0.64 | |
| DAM92 | EPH-DAM FEIGEN 2/92 MAN 1 | mandibua | F | <LOD | N/A | N/A | N/A | N/A | ||||||||||
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| N/A | N/A | N/A | N/A | |
| DAM92 | EPH-DAM FEIGEN 3/92 lPAT 9 | patella | F | −19.0 | 9.8 | 6.8 | 39.6 | 14.5 | 0.11 | 3.8 | 3.2 | 2.1 | 0.5 | N/A | N/A | N/A | N/A | |
| Infants | DAM94 | EPH-DAM 127/94 rULN | ulna | N/A | −18.9 | 9.5 | 8.0 | 42.3 | 15.6 | 0.08 | 5.4 | 3.2 | 2.0 | 0.4 | N/A | N/A | N/A | N/A |
| DAM94 | EPH-DAM 148/94 lPUB 1 | pubis | N/A | −18.9 | 8.2 | 5.1 | 43.0 | 16.5 | 0.06 | 6.9 | 3.0 | 3.2 | 0.6 | N/A | N/A | N/A | N/A | |
| DAM94 | EPH-DAM 148/94 lPUB 2 | pubis | N/A | −19.3 | 9.3 | 7.7 | 41.2 | 15.6 | 0.11 | 4.5 | 3.1 | 2.0 | 0.4 | N/A | N/A | N/A | N/A | |
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| N/A | N/A | N/A | N/A | |
| DAM93NG | EPH-DAM 214/93 MAN 1 | mandibula | N/A | <LOD | N/A | N/A | N/A | N/A | ||||||||||
| DAM92 | EPH-DAM FEIGEN 3/92 rFEM 3 | femur | N/A | <LOD | N/A | N/A | N/A | N/A | ||||||||||
|
|
|
|
|
| N/A | N/A | N/A | N/A | ||||||||||
|
|
|
|
| − |
|
|
|
|
|
|
|
|
| N/A | N/A | N/A | N/A |
Individuals excluded due to collagen quality criteria are shown in italic type; LOD, limit of detection; N/A, not applied; F, female; M, male.
Data of calcium (Ca); Ca/P-ratios, strontium (Sr), and Sr/Ca-ratios, as well as lanthanum (La) and pH for the analyzed samples of animal and cremated human bones respectively total soil and soil eluents.
| Sample-ID | Specimen | Ca [mg/g] | Ca/P | Sr [μg/g] | Sr/Ca [μg/mg] | La [μg/g] | pH |
| EPH-DAM-P-I/93-HOMO | cremated human bone | 368.1 | 2.18 | 211.9 | 0.58 | N/A | N/A |
| EPH-DAM-P-II/93-HOMO | cremated human bone | 376.2 | 2.17 | 229.8 | 0.61 | N/A | N/A |
| EPH-DAM92-SOIL | soil | 114.6 | 11.1 | 171.5 | 1.50 | 53.5 | N/A |
| EPH-DAM93G-SOIL | soil | 56.9 | 17.7 | 122.4 | 2.15 | 55.7 | N/A |
| EPH-DAM93NG-SOIL | soil | 42.2 | 31.2 | 102.7 | 2.43 | 50.0 | N/A |
| EPH-DAM94-SOIL | soil | 122.0 | 47.1 | 196.5 | 1.61 | 46.9 | N/A |
| EPH-DAM92-ELU | soil eluent | 868.9 | 14.0 | 2.92 | 3.36 | <LOD | 7.30 |
| EPH-DAM93G-ELU | soil eluent | 535.8 | 19.3 | 1.52 | 2.84 | <LOD | 7.72 |
| EPH-DAM93NG-ELU | soil eluent | 479.3 | 24.4 | 1.46 | 3.05 | <LOD | 7.66 |
| EPH-DAM94-ELU | soil eluent | 875.4 | 52.0 | 2.78 | 3.18 | <LOD | 7.14 |
*… μg/L.
Instrumentation characteristics for the ICP-OES measurements.
| Element | Ca | P | Sr | La |
| Wavelenght [nm] | 317.933 | 213.618 | 407.771 | 379.478 |
| Dilution | 500 mg in 1 L | 500 mg in 1 L | 500 mg in 1 L | 500 mg in 10 mL |
| LOD [μg/g] | 44.8 | 145 | 0.282 | 0.0910 |
| Recovery rate SMR1468 [%] | 100.7 | 99.9 | 100.4 | N/A |
| Precision | 2.3 | 2.5 | 1.0 | N/A |
| Recovery rate SMR2711 [%] | 101.4 | 98.9 | 101.4 | 97.0 |
| Precision | 2.7 | 2.2 | 1.7 | 2.9 |
* … Precision was estimated from the deviation of six independent replicates.
LOD … Limit of detection if sample weight is 500 mg ashed (500°C) bone.
Basic statistics for stable isotope ratios and Sr/Cr data.
| δ13C [‰]V-PDB | δ15N [‰]AIR | δ34S [‰]V-CDT | Sr/Ca [μg/mg] | |||||||||||||||||||
| Group |
| Mean | SD | Median | Min | Max | Mean | SD | Median | Min | Max | Mean | SD | Median | Min | Max |
| Mean | SD | Median | Min | Max |
| Gladiators | 20 | −18.9 | 0.4 | −19.0 | −19.4 | −17.8 | 9.3 | 0.8 | 9.3 | 7.6 | 11.2 | 7.5 | 1.9 | 8.1 | 3.4 | 11.2 | 21 | 1.26 | 0.33 | 1.21 | 0.78 | 1.94 |
| NG-males | 13 | −19.0 | 0.2 | −18.9 | −19.6 | −18.7 | 9.4 | 0.6 | 9.2 | 8.8 | 10.5 | 7.3 | 1.1 | 7.0 | 5.4 | 9.1 | 11 | 0.68 | 0.10 | 0.68 | 0.52 | 0.84 |
| Females | 4 | −18.9 | 0.5 | −19.1 | −19.4 | −18.2 | 8.9 | 1.1 | 9.2 | 7.4 | 9.8 | 7.2 | 3.0 | 6.8 | 3.9 | 11.2 | 3 | 0.65 | 0.02 | 0.65 | 0.64 | 0.67 |
| Infants | 3 | −19.0 | 0.2 | −18.9 | −19.3 | −18.9 | 9.0 | 0.7 | 9.3 | 8.2 | 9.5 | 6.9 | 1.6 | 7.7 | 5.1 | 8.0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Total | 40 | −18.9 | 0.4 | −19.0 | −19.6 | −17.8 | 9.3 | 0.8 | 9.2 | 7.4 | 11.2 | 7.4 | 1.7 | 7.6 | 3.4 | 11.2 | 35 | 1.03 | 0.39 | 0.95 | 0.52 | 1.94 |
NG, non gladiator; SD, standard deviation; N/A, not applied.
Kruskal-Wallis respectively Mann-Whitney U tests performed for gladiator and non gladiator groups.
| Group | Variables |
|
| Gladiators | δ13C | 0.828 |
| δ15N | 0.850 | |
| δ34S | 0.668 | |
| Sr/Ca | 0.586 | |
| Gladiators | δ13C | 0.821 |
| δ15N | 0.775 | |
| δ34S | 0.407 | |
| Sr/Ca |
|
Significant p values are bold; NG, non gladiator.
Ratios of Ca and Sr for bone vs. total soil vs. soil eluent and bone vs. soil eluent gradients, as well as Sr/Ca-ratios in bone, soil and eluent for all investigated excavation locations.
| Ca-ratios | Sr-ratios | Sr/Ca-ratios [μg/mg] | |||||
| Location | bone/soil/eluent | bone/eluent | bone/soil/eluent | bone/eluent | bone | soil | eluent |
| DAM92 | 3.05: 1: 0.0076 | 402.5: 1 | 1.38: 1: 0.0170 | 81.0: 1 | 0.68 | 1.50 | 3.36 |
| DAM93G | 6.39: 1: 0.0094 | 678.0: 1 | 3.76: 1: 0.0124 | 302.3: 1 | 1.26 | 2.15 | 2.84 |
| DAM93NG | 8.53: 1: 0.0114 | 751.2: 1 | 2.21: 1: 0.0142 | 155.3: 1 | 0.63 | 2.43 | 3.05 |
| DAM94 | 3.01: 1: 0.0072 | 420.1: 1 | 1.28: 1: 0.0142 | 90.2: 1 | 0.68 | 1.61 | 3.18 |
Figure 3Stable δ13C and δ15N ratios.
Comparison between different groups (gladiators, NG-males, and NG-females).
Figure 4Stable δ13C and δ34S ratios.
Comparison between different groups (gladiators, NG-males, and NG-females).
Figure 5Sr/Ca ratios.
Individual values and comparison between different groups (gladiators, NG-all, NG-males, and females).